Luminex's average Accounts Receivable for the
three
months ended in Mar. 2021 was $68.0 Mil. Luminex's Revenue for the
three
months ended in Mar. 2021 was $110.7 Mil.
Hence, Luminex's Days Sales Outstanding for the
three
months ended in Mar. 2021 was 56.06.
The historical rank and industry rank for Luminex's Days Sales Outstanding or its related term are showing as below:
LMNX'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 40.67 Med: 48.23 Max: 58.88
Current: 54.2
During the past 13 years, Luminex's highest Days Sales Outstanding was 58.88. The lowest was 40.67. And the median was 48.23.
LMNX's Days Sales Outstanding is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 63.94
vs LMNX: 54.20
Luminex's Days Sales Outstanding
declined
from Mar. 2020 (60.40) to Mar. 2021 (56.06).
Luminex Days Sales Outstanding Historical Data
The historical data trend for Luminex's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Luminex's Days Sales Outstanding
For the Medical Instruments & Supplies subindustry, Luminex's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Luminex's Days Sales Outstanding Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Luminex's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Luminex's Days Sales Outstanding falls into.
Luminex Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Luminex (NAS:LMNX) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Luminex Days Sales Outstanding Related Terms
Thank you for viewing the detailed overview of Luminex's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.
Luminex Corp develops, manufactures, and sells proprietary biological testing technologies and products to testing laboratories. It primarily serves the life sciences industries by selling products used by laboratory professionals and clinical laboratories in performing diagnostics, drug research and discovery, and clinical tests on patients. Luminex's market segments mainly include Infectious disease, Personalized medicine, and Human genetics. It offers various solutions in diverse markets, including clinical diagnostics, pharmaceutical drug discovery, biomedical research, genomic and proteomic research, and food safety. The vast majority of the company's revenue is earned in the United States. The products offered are xMAP Products, ARIES Products and VERIGENE Products, among others.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
LMNX has been successfully added to your 